Amgen Ltd: UK Public Sector Contracts Won & Awards
Large organisation·Companies House: Private Limited Company·Cambridge·Nationwide (UK)·Main market: Pharmaceutical products
Official UK PPONPDJG-8184-TCQQCompanies House02354269 ↗ · Active
Where they wini
i
56 awards (53 for a named lot, 95%, 3 for a whole procedure with no lot named) · top CPV classes, shares of all 56 awards. An award may cover more than one class.
3360 Pharmaceutical products56 awards · 100% · 53 awards naming a lot + 3 whole-procedure awardsi
i
Where their buyers arei
i
ITL1 region of the buyer office · known for 49 of 49 awarded procedures · each procedure counts once
Bidding recordi
i
Procurement Act 2023 award notices name every bidder · 4 notices name this supplier, covering 6 lots since 6 Oct 2025 · observed bids, not an estimate
i
i
i
| Notice | Authority | Outcome | Bidders | Published |
|---|---|---|---|---|
| NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026 | NHS England | appointed | 25 | 21 Jul 2026 |
| NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 | NHS England | appointedall 2 lots bid for | 26 | 10 Jul 2026 |
| NHS National Framework for Denosumab Injection commencing 1st January 2026 | NHS England | appointed to 1 of 2 lots | 13 | 4 Dec 2025 |
| NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025 | NHS England | undecided | 17 | 6 Oct 2025 |
Bidder names come from Procurement Act 2023 award notices, which list every bidder (from 2025). Older notices name no bidders, so earlier contests do not appear here. Latest ten notices shown.
Who they sell toi
i
Authorities named on this supplier’s published awards · ranked by distinct procedures · a framework or DPS adds one award record per appointed supplier
i
NHS & health89%(50 awards)
50 of 56 awards are NHS & health (89%).Type not classified11%(6 awards)
6 of 56 awards are Type not classified (11%).
| Authority | Procedures | Share | Award records | Last activity |
|---|---|---|---|---|
| NHS England | 26 | 53.1% | 35 | 6 Jul 2026 |
| The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") | 8 | 16.3% | 12 | 18 Dec 2025 |
| NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) | 8 | 16.3% | 8 | 4 Jun 2026 |
| The NHS Commissioning Board (operating under the name of NHS England) | 4 | 8.2% | 6 | 7 Feb 2022 |
| Business Services Organisation Procurement and Logistics Service | 2 | 4.1% | 5 | 12 Jun 2025 |
| eTenderwales | 1 | 2% | 1 | 23 Apr 2025 |
Share = of the 49 procedures with an award naming this supplier. Last activity = award date, or notice publication when no award date was published.
Contracts endingi
i
53 of 67 awards carry an end date, 10 estimated from the duration · not a retender forecast
| Contract | Ends | Published value |
|---|---|---|
| Lot 2 - CM/TNS/25/5725/02 | 31 Dec 2026 | £15,059,000 ceiling |
| Cancer Medicines (Group 2) | 31 Jan 2027 | £18,207,081 ceiling |
| NP49425 Generic and Biosimilar Transition Medicines | 28 Feb 2027 | £64,103,740 ceiling |
| Medicinal Products - Direct to Trust | 2 Jun 2027 estimated | £210,000,000 ceiling |
| Medicinal Products - with Pharma Funded Homecare Services | 2 Jun 2027 estimated | £174,000,000 ceiling |
| NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 | 31 Aug 2027 | £986,282,758 |
| NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National | 31 Aug 2027 | £261,895,933 |
| Lot 2 - CM/PHR/25/5731/02 - Ustekinumab NOFE & MAE | 31 Aug 2027 | £18,903,212 ceiling |
| Transitional Drugs 6 | 29 Feb 2028 | £1,637,726 |
| NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024 | 30 Apr 2028 | £1 ceiling |
Recent awards
Latest 30 of 56 award records naming this supplier
Contracts Finder adds 11 more procedures won by this supplier, mostly below the Find a Tender threshold or from before 2025. Each is counted once beside any Find a Tender copy; they are in the totals, not in this list.
About this data
- One profile per supplier. Built from award and contract notices that name this supplier; different spellings and registration numbers of the same company are merged into this profile.
- Values are published values. The table mirrors what the notice published: framework ceilings and joint awards are labelled and never counted as this supplier's money, and † marks a value taken from the contract notice when the award published none. Only awards made to this supplier alone count towards its value, excluding VAT. It is not turnover.
- Regions in the buyer chart describe the buyer office, not where the work is delivered or the supplier’s registered address.
- Contract end dates. Published on 43 of 67 awards, estimated from the published duration on 10 more (marked “estimated”); those feed “Contracts ending”. Published values in that list come from either source; Contracts Finder figures are shown as published and stay out of this profile’s money totals.
- Source. Official UK public procurement notices (Find a Tender and Contracts Finder), reused under the Open Government Licence v3.0, updated through the day and rebuilt nightly. Not every figure uses both feeds, and each one shows how many records it rests on: see the methodology. Spotted something wrong? Tell us.